NCT05489211 2026-03-19Study of Dato-DXd as Monotherapy and in Combination With Anti-cancer Agents in Patients With Advanced Solid Tumours (TROPION-PanTumor03)AstraZenecaPhase 2 Recruiting454 enrolled
NCT05084859 2024-08-09A Study Evaluating the Safety, Pharmacokinetics, and Preliminary Efficacy of Orally Administered SM08502 Combined With Hormonal Therapy or Chemotherapy in Subjects With Advanced Solid TumorsBiosplice Therapeutics, Inc.Phase 1 Terminated30 enrolled